China's healthcare-focused LYFE Capital leads $92m funding in biotech firm ABclonal

China's healthcare-focused LYFE Capital leads $92m funding in biotech firm ABclonal

Photo: Pixabay

18 December, 2020

ABclonal Technology biology life science tools Lyfe Capital

Printed by Unregistered user on Thu, 24 Jul 2025 03:49:50 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Chinese life science solutions provider Taimei closes $176m

Life science investor Novo Holdings expanding to Asia, sets up SG office

Read more from Greater China

China launches national fusion energy firm, state-owned firms inject $1.6b

Amazon shuts down Shanghai AI research lab: report